Lucky buyers at 1c. This stock refused to go below 1.1c before...

Lucky buyers at 1c. This stock refused to go below 1.1c before the elections. With this update, we should not even be trading at 1.5c
Compass contract numbers will be announced as soon as the lawyers are done and contract is signed.
As per the ann, the UK and Canada licenses alone will be material in terms of revenue. Other countries ?

Ilumen on its own could be a Software company maker. User feedback is good and there is a clear revenue path. How much longer before another deal is announced? That existing clients renewed their licences is a testament to the high value proposition. We have reputable organisations to reference on our marketing campaign.

On the regulated side of the business, MEBsleep offers a separate revenue path. We only need FDA clearance and CE mark to market in the US and Europe respectively.
Then we have MEB-001 with an addressable market of US$276m per annum in the US alone.

C'mon guys, don't be short-sighted. Rerate your portfolio with this company. DYOR